All-trans retinoic acid induced gene expression and growth inhibition in head and neck cancer cell lines

European Journal of Cancer Part B: Oral Oncology

Volumn 33, Issue 4, 1997, Pages 270-274

  Copper, M P ^a   Klaassen, I ^a   Brakenhoff, R H ^a   Cloos, J ^a   Snow, G B ^a   Braakhuis, B J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokeratin; Differentiation; Head and neck cancer; Retinoid; Retinoid receptor; Squamous cancer; Steroid receptor; Thyroid receptor; Vitamin A

Indexed keywords

MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE EXPRESSION; GROWTH INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; KERATINS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROTEINS; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; RNA, NEOPLASM; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031195108     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(97)00024-9     Document Type: Article

References (40)

1. 1. Haughey, B. H., Gates, G. A., Arfken, C. L. and Harvey, J., Meta-analysis of second malignant tumors in head and neck cancer: The case for an endoscopic screening protocol. Annals of Otology, Rhinology and Laryingology, 1992, 101, 105-112.
2. 2. Tepperman, B. S. and Fitzpatrick, P. J., Second respiratory and upper digestive tract cancers after oral cancer. Lancet, 1981, ii, 547-549.
3. 3. Slaughter, D. P., Multicentric origin of intraoral carcinoma. Surgery, 1946, 20, 133-146.
4. 4. Copper, M. P., Braakhuis, B. J. M., De Vries, B., Van Dongen, G. A. M. S., Nauta, J. J. P. and Snow, G. B., A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate end points in chemoprevention trials. Cancer, 1993, 71, 825-830.
5. 5. Brugère, J., Guenel, P., Leclerc, A. and Rodriguez, J., Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth. Cancer, 1986, 56, 391-395.
6. 6. Day, G. L., Blot, W. J., Shore, R. E., et al., Second cancers following oral and pharyngeal cancers: Role of tobacco and alcohol. Journal of the National Cancer Insitute, 1994, 2, 131-137.
7. 7. De Vries, N., The magnitude of the problem. In Multiple Primary Tumors in the Head and Neck, eds N. De Vries and J. L. Gluckman. Georg Thieme, Stuttgart, 1990, pp. 1-29.
8. 8. Salonen, J. T., Salonen, R., Lappetelänen, R., Maenpää, P. H., Alfthan, G. and Puska, P., Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. British Medical Journal, 1985, 290, 417-420.
9. 9. Stähelin, H. B., Rösel, F., Buess, E. and Brubacher, G., Cancer, vitamins and plasma lipids: prospective Basel study. Journal of the National Cancer Institute, 1984, 73, 1463-1468.
10. 10. Zheng, W., Blot, W. J., Diamond, E. L., et al., Serum micronutrients and the subsequent risk of oral and pharyngeal cancer. Cancer Research, 1993, 53, 795-798.
11. 11. Bollag, W. and Holdener, E. E., Retinoids in cancer prevention and therapy. Annals of Oncology, 1992, 3, 513-526.
12. 12. Hong, W. K., Lippman, S. M., Itri, L. M., et al., Prevention of second primary tumors with isotrenoin in squamous-cell carcinoma of the head and neck. New England Journal of Medicine, 1990, 323, 795-801.
13. 13. Lippman, S. M., Batsakis, J. G., Toth, B. B., et al., Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. New England Journal of Medicine, 1993, 328, 15-20.
14. 14. Pastorino, U., Infante, M., Maioli, M., et al., Adjuvant treatment of stage I lung cancer with high-dose vitamin A. Journal of Clinical Onocology, 1993, 11, 1216-1222.
15. 15. Strickland, S. and Mahdavi, V., The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell, 1978, 15, 393-103.
16. 16. Lotan, R., Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochemica Biophysica Acta, 1980, 605, 33-91.
17. 17. Warrell, R. P., Retinoid resistance. Lancet, 1993, 341, 126.
18. 18. De Vries, N., Van Zandwijk, N. and Pastorino, U., The Euroscan study. British Journal of Cancer, 1991, 64, 985-989.
19. 19. Alpha-tocopherol Beta Carotene Cancer Prevention Study Group, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine, 1994, 330, 1029-1035.
20. 20. Omenn, G. S., Goodman, G. E., Thornquist, M. D., et al., Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine, 1996, 334, 1150-1155.
21. 21. Petkovich, M., Brand, N. J., Krust, A. and Chambon, P., A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature, 1987, 330, 444-450.
22. 22. Giguere, V., Ong, E., Segui, P. and Evans, R. M., Identification of a receptor for the morphogen retinoic acid. Nature, 1987, 330, 624-629.
23. 23. Brand, N., Petkovich, M., Krust, A., et al., Identification of a second human retinoic acid receptor. Nature, 1988, 332, 850-853.
24. 24. Krust, A., Kastner, P., Petkovich, M., Kastner, P. and Chambon, P., A third human retinoic acid receptor, hRAR-γ. Proceedings of the National Academy of Science, 1989, 86, 5310-5314.
25. 25. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A. and Evans, R. M., Nuclear receptor that identifies a novel retinoic acid response pathway. Nature, 1990, 345, 224-229.
26. 26. Braakhuis, B. J. M., Jansen, G., Noordhuis, P., Kegel, A. and Peters, G. J., Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma. Biochemical Pharmacology, 1994, 46, 2155-2161.
27. 27. Sambrook, J., Fritsch, E. F. and Maniatis, T., Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press, New York, 1989.
28. 28. Feinberg, A. P. and Vogelstein, B. A., A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry, 1983, 132, 6-13.
29. 29. Gough, N. M., Rapid and quantitative preparation of cytoplasmic RNA from small numbers of cells. Analytical Biochemistry, 1988, 173, 93-95.
30. 30. Morgan, P. R., Leigh, I. M., Purkis, P. E., Gardner, I. D., Van Muijen, G. N. P. and Lane, E. B., Site variation in keratin expression in human oral epithelia - an immunocytochemical study of individual keratins. Epithelia, 1987, 1, 31-43.
31. 31. Gibbs, S., Fijneman, R., Wiegand, J., Geurts van Kessel, A., Van De Putte, P. and Backendorf, C., Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics, 1993, 16, 630-637.
32. 32. Jetten, A. M., Kim, J. S., Sacks, P. G., et al., Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all-trans retinoic acid. International Journal of Cancer, 1990, 45, 195-202.
33. 33. Parkinson, E. K., Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumor promotion by phorbol esters and by deep skin wounding. British Journal of Cancer, 1985, 52, 479-493.
34. 34. Lotan, R., Xu, X. C., Lippman, S. M., et al., Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoins. New England Journal of Medicine, 1995, 332, 1405-1410.
35. 35. Xu, X. C., Ro, J. Y., Lee, J. S., Shin, D. M., Hong, W. K. and Lotan, R., Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Research, 1994, 54, 3580-3587.
36. 36. Hoffman, A. D., Engelsten, D., Bogenrieder, T., et al., Expression of retinoic acid receptor-β in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid. Clinical Cancer Research, 1996, 2, 1077-1082
37. 37. Jing, Y., Zhang, J., Bleiweiss, I. J., Waxman, S., Zelent, A. and Mira-Y-Lopez, R., Defective expression of cellular retinol binding protein type I and retinoic acid receptors α2, β2, and γ2 in human breast cancer cells. FASEB Journal, 1996, 10, 1064-1070.
38. 38. Delva, L., Cornic, M., Balitrand, N., et al., Resistance to all-trans-retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia - study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood, 1993, 82, 2175-2181.
39. 39. Åström, A., Tavakkol, A., Petterson, U., Cromie, M., Elder, J. T. and Voorhees, J. J., Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). Retinoic acid-induced expression of CRABP-II but not CRABP-I in adult human skin in vivo and in skin fibroblasts in vitro. Journal of Biology and Chemistry, 1991, 266, 17662-17666.
40. 40. Braakhuis, B. J. M., Klaassen, I., van der Leede, B. M., et al., Retinoid metabolism and all-trans retinoic acid induced growth inhibition in head and neck squamous cell carcinoma cell lines. British Journal of Cancer, 1997, 76, 189-197.